In the context of these complexities, our study is focused into the in vitro identification of novel molecular mechanisms influencing tumor growth and metabolic parameters, alongside NF-κB activity, revealing a crucial role of the fatty acid transporter FABP5 in driving metabolic alterations and inflammation. This evidence concerns the gene FABP5 and neoplasm.